Bionano Genomics Inc BNGO:NASDAQ

Last Price$2.42Cboe Real-Time Last Sale as of 12:18PM ET 1/18/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.13(5.10%)
Bid (Size)$2.42 (5,200)
Ask (Size)$2.43 (4,300)
Day Low / High$2.40 - 2.55
Volume3.7 M

View Biotechnology IndustryPeer Comparison as of 01/18/2022


Bionano Genomics Inc ( NASDAQ )

Price: $2.42
Change: -0.13 (5.10%)
Volume: 3.7 M
12:18PM ET 1/18/2022

Seres Therapeutics Inc ( NASDAQ )

Price: $7.63
Change: -0.41 (5.10%)
Volume: 156.0 K
12:21PM ET 1/18/2022

Vaxart Inc ( NASDAQ )

Price: $5.64
Change: -0.23 (3.92%)
Volume: 1.0 M
12:20PM ET 1/18/2022

Stoke Therapeutics Inc ( NASDAQ )

Price: $19.09
Change: -0.49 (2.50%)
Volume: 51.5 K
12:19PM ET 1/18/2022

Scholar Rock Holding Corp ( NASDAQ )

Price: $19.51
Change: -0.72 (3.56%)
Volume: 33.8 K
12:20PM ET 1/18/2022

Read more news Recent News

Bionano Genomics Reports Sharp Rise in Preliminary Q4, 2021 Revenue; Shares Gain Premarket
8:39AM ET 1/12/2022 MT Newswires

Bionano Genomics (BNGO) reported preliminary Q4 2021 revenue of $5.8 million to $6.2 million, an estimated increase of 45% to 55% compared with a year...

Bionano Genomics Completes Prototype For Its Next Single Molecule Imaging System
9:10AM ET 12/29/2021 MT Newswires

Bionano Genomics (BNGO) said Wednesday it completed the first prototype for its next single-molecule imaging system for optical genome mapping, or OGM. ...

BioNano Genomics Says Johns Hopkins University Study Backs Use of Optical Genome Mapping in Cancer
10:25AM ET 11/22/2021 MT Newswires

BioNano Genomics (BNGO) said Monday a study by the Johns Hopkins University supporting the use of optical genome mapping in cancer analysis has been...

Bionano Genomics to Buy BioDiscovery
8:23AM ET 10/12/2021 MT Newswires

Bionano Genomics (BNGO) said Tuesday it has agreed to purchase BioDiscovery, a software company that offers services for analysis, interpretation and...

Company Profile

Business DescriptionBionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA. View company web site for more details
Address9540 Towne Centre Drive
San Diego, California 92121
Number of Employees77
Recent SEC Filing01/12/20228-K
President, CEO, Secretary & DirectorRobert Erik Holmlin
Chief Operating OfficerMark Oldakowski
Chief Financial & Accounting OfficerChristopher Stewart
Chief Medical OfficerAlka Chaubey

Company Highlights

Price Open$2.50
Previous Close$2.55
52 Week Range$2.40 - 15.69
Market Capitalization$699.8 M
Shares Outstanding289.2 M
SectorHealth Technology
Next Earnings Announcement03/22/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.24
Beta vs. S&P 500N/A
Revenue$12.0 M
Net Profit Margin-390.68%
Return on Equity-22.56%

Analyst Ratings as of 06/15/2021

Consensus RecommendationConsensus Icon
Powered by Factset